Condensed Statements of Changes of Shareholders Equity - USD ($)
|
Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Treasury Stock |
Total |
| Balances, Beginning at Dec. 31, 2021 |
$ 833
|
$ 58,425,604
|
$ (43,925,373)
|
|
$ 14,501,064
|
| Balances, Beginning (in shares) at Dec. 31, 2021 |
8,330,390
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Share-based compensation expense |
|
131,906
|
|
|
131,906
|
| Net loss |
|
|
(3,960,308)
|
|
(3,960,308)
|
| Balances, Ending at Mar. 31, 2022 |
$ 833
|
58,557,510
|
(47,885,681)
|
|
10,672,662
|
| Balances, Ending (in shares) at Mar. 31, 2022 |
8,330,390
|
|
|
|
|
| Balances, Beginning at Dec. 31, 2021 |
$ 833
|
58,425,604
|
(43,925,373)
|
|
14,501,064
|
| Balances, Beginning (in shares) at Dec. 31, 2021 |
8,330,390
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net loss |
|
|
|
|
(10,203,278)
|
| Balances, Ending at Sep. 30, 2022 |
$ 1,833
|
63,351,653
|
(54,128,651)
|
|
9,224,835
|
| Balances, Ending (in shares) at Sep. 30, 2022 |
18,330,390
|
|
|
|
|
| Balances, Beginning at Mar. 31, 2022 |
$ 833
|
58,557,510
|
(47,885,681)
|
|
10,672,662
|
| Balances, Beginning (in shares) at Mar. 31, 2022 |
8,330,390
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Share-based compensation expense |
|
136,957
|
|
|
136,957
|
| Net loss |
|
|
(3,667,255)
|
|
(3,667,255)
|
| Balances, Ending at Jun. 30, 2022 |
$ 833
|
58,694,467
|
(51,552,936)
|
|
7,142,364
|
| Balances, Ending (in shares) at Jun. 30, 2022 |
8,330,390
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Proceeds from issuance of common stock, net of issuance costs |
$ 1,000
|
4,492,920
|
|
|
4,493,920
|
| Issuance of common shares, net of costs (shares) |
10,000,000
|
|
|
|
|
| Share-based compensation expense |
|
164,266
|
|
|
164,266
|
| Net loss |
|
|
(2,575,715)
|
|
(2,575,715)
|
| Balances, Ending at Sep. 30, 2022 |
$ 1,833
|
63,351,653
|
(54,128,651)
|
|
9,224,835
|
| Balances, Ending (in shares) at Sep. 30, 2022 |
18,330,390
|
|
|
|
|
| Balances, Beginning at Dec. 31, 2022 |
$ 1,833
|
63,497,868
|
(56,173,207)
|
|
7,326,494
|
| Balances, Beginning (in shares) at Dec. 31, 2022 |
18,330,390
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Share-based compensation expense |
|
161,697
|
|
|
161,697
|
| Net loss |
|
|
(1,516,864)
|
|
(1,516,864)
|
| Balances, Ending at Mar. 31, 2023 |
$ 1,833
|
63,659,565
|
(57,690,071)
|
|
5,971,327
|
| Balances, Ending (in shares) at Mar. 31, 2023 |
18,330,390
|
|
|
|
|
| Balances, Beginning at Dec. 31, 2022 |
$ 1,833
|
63,497,868
|
(56,173,207)
|
|
$ 7,326,494
|
| Balances, Beginning (in shares) at Dec. 31, 2022 |
18,330,390
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Exercise of warrants (in shares) |
|
|
|
|
285,674
|
| Shares surrendered in cashless warrant exercises |
|
|
|
|
$ (299,129)
|
| Shares surrendered in cashless warrant exercises (in shares) |
|
|
|
|
192,951
|
| Net loss |
|
|
|
|
$ (4,192,842)
|
| Balances, Ending at Sep. 30, 2023 |
$ 1,926
|
65,424,994
|
(60,366,049)
|
$ (299,110)
|
4,761,761
|
| Balances, Ending (in shares) at Sep. 30, 2023 |
19,257,937
|
|
|
|
|
| Balances, Beginning at Mar. 31, 2023 |
$ 1,833
|
63,659,565
|
(57,690,071)
|
|
5,971,327
|
| Balances, Beginning (in shares) at Mar. 31, 2023 |
18,330,390
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Exercise of warrants |
$ 47
|
292,208
|
|
|
292,255
|
| Exercise of warrants (in shares) |
467,625
|
|
|
|
|
| Shares surrendered in cashless warrant exercises |
$ (19)
|
|
|
(292,236)
|
(292,255)
|
| Shares surrendered in cashless warrant exercises (in shares) |
(189,560)
|
|
|
|
|
| Share-based compensation expense |
|
161,664
|
|
|
161,664
|
| Net loss |
|
|
(1,440,904)
|
|
(1,440,904)
|
| Balances, Ending at Jun. 30, 2023 |
$ 1,861
|
64,113,437
|
(59,130,975)
|
(292,236)
|
4,692,087
|
| Balances, Ending (in shares) at Jun. 30, 2023 |
18,608,455
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Proceeds from issuance of common stock, net of issuance costs |
$ 64
|
1,156,379
|
|
|
1,156,443
|
| Issuance of common shares, net of costs (shares) |
641,873
|
|
|
|
|
| Exercise of warrants |
$ 1
|
6,873
|
|
|
6,874
|
| Exercise of warrants (in shares) |
11,000
|
|
|
|
|
| Shares surrendered in cashless warrant exercises |
|
|
|
(6,874)
|
(6,874)
|
| Shares surrendered in cashless warrant exercises (in shares) |
(3,391)
|
|
|
|
|
| Share-based compensation expense |
|
148,305
|
|
|
148,305
|
| Net loss |
|
|
(1,235,074)
|
|
(1,235,074)
|
| Balances, Ending at Sep. 30, 2023 |
$ 1,926
|
$ 65,424,994
|
$ (60,366,049)
|
$ (299,110)
|
$ 4,761,761
|
| Balances, Ending (in shares) at Sep. 30, 2023 |
19,257,937
|
|
|
|
|